Performance and Clinical Utility of a Commercial von Willebrand Factor Collagen Binding Assay for Laboratory Diagnosis of von Willebrand Disease | Zendy

Joanna M. Popov | Zendy; Olga S. Zhukov | Zendy; Susan Ruden | Zendy; Terry Zeschmann | Zendy; Anthony Sferruzza | Zendy; Mervyn A. Sahud | Zendy

Open Access

Performance and Clinical Utility of a Commercial von Willebrand Factor Collagen Binding Assay for Laboratory Diagnosis of von Willebrand Disease

Author(s) -

Joanna M. Popov,

Olga S. Zhukov,

Susan Ruden,

Terry Zeschmann,

Anthony Sferruzza,

Mervyn A. Sahud

Publication year - 2006

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2006.070730

Subject(s) - von willebrand disease , von willebrand factor , ristocetin , coagulopathy , chemistry , microbiology and biotechnology , antigen , immunology , medicine , platelet , biology

Von Willebrand disease (VWD) diagnosis and classification usually require a combination of nonspecific and VW-factor (VWF)-specific assays. We evaluated the analytical performance of a commercially available collagen-binding assay (CBA) and its usefulness in conjunction with other assays for laboratory diagnosis of VWD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research